Effects of sibutramine on ventricular dimensions and heart valves in obese patients during weight reduction

American Heart Journal

Volumn 144, Issue 3, 2002, Pages 508-515

  Zannad, Faiez ^a   Gille, Bertrand ^a   Grentzinger, Alain ^b   Bruntz, Jean François ^c   Hammadi, Mokrane ^a   Boivin, Jean Marc ^a   Hanotin, Corinne ^d   Igau, Bruno ^d   Drouin, Pierre ^a  

^a Ctr Hospitalier Univ de Nancy   (France)

^b CHU NANCY BRABOIS   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

^d Laboratoires Knoll France   (France)

Author keywords

[No Author keywords available]

Indexed keywords

SIBUTRAMINE;

ADULT; ARTICLE; BACKACHE; BLOOD PRESSURE MONITORING; BODY MASS; BRONCHITIS; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTROCARDIOGRAM; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART RATE; HEART VALVE; HEMODYNAMICS; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; OBESITY; PHARYNGITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WEIGHT REDUCTION; XEROSTOMIA;

EID: 0036733520     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2002.124403     Document Type: Article

References (43)

1. Obesity and hypertension
2. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study
3. Separate and joint influences of obesity and mild hypertension on left ventricular mass and geometry: The Framingham Heart Study
4. Adiposity of the heart
5. The cardiomyopathy of obesity
6. Obesity and the heart
7. Blood volume, cardiac output and distribution of systemic blood flow in extreme obesity
8. Left ventricular hypertrophy and cardiovascular prognosis
9. Considerations in the use of echocardiography in epidemiology. The Framingham Study
10. The effect of weight reduction on left ventricular mass: A randomized controlled trial in young, overweight hypertensive patients
11. Effect of weight loss on left ventricular mass in nonhypertensive morbidity obese
12. Reduction of weight and left ventricular mass with serotonin uptake inhibition in obese patients with systemic hypertension
13. Weight reduction regresses left ventricular mass regardless of blood pressure level in obese subjects
14. Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults
15. Effects of obesity and weight loss on left ventricular mass and relative wall thickness: Survey and intervention study
16. Valvular heart disease associated with fenfluramine-phentermine
17. The prevalence of cardiac valvular insufficiency assessed by thansthoracic echocardiography in obese patients treated with appetite-suppressant drugs
18. An assessment of heart-value abnormalities in obese patients taking dexfenfluramine, sustained-release denfenfluramine, or placebo
19. Heart valve lesions in patients treated with appetite suppressants
20. Prevalence and determinants of valvulopathy in patients treated with dexfenfluramine
21. Sibutramine: A novel anti-obesity drug: A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine
22. Sibutramine: A review of its contribution to the management of obesity
23. An assessment of the safety and efficacy of sibutramine, an anti-obesity drug with a novel mechanism of action
24. Clinical cardiovascular effects of sibutramine
25. Absence of cardiac valve dysfunction in obese patients treated with sibutramine
26. Centralized echocardiogram quality control in a multicenter study of regression of left ventricular hypertrophy in hypertension
27. Recommendations concerning use of echocardiography in hypertension and general population research
28. Two-dimensional echocardiographic determination of left ventricular volume, systolic function, and mass: Summary and discussion of the 1989 recommendations of the American Society for Echocardiography
29. Echocardiographic determination of left ventricular mass in man: Anatomie validation of the method
30. A new method for indexing left ventricular mass for difference in body size
31. Color Doppler assessment of mitral regurgitation with orthogonal planes
32. Evaluation of aortic insufficiency by Doppler color flow mapping
33. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study
34. The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study
35. Reproducibility of echocardiographic left ventricular measurements
36. Sibutramine produces dose-related weight loss
37. A single-dose, placebo-controlled, comparative evaluation of the cardiovascular effects of sibutramine and amitriptyline in normal volunteers